<p>Chronic infections and cancer cause T cell dysfunction known as exhaustion. This cell state is caused by persistent antigen exposure, suboptimal co-stimulation and a plethora of hostile factors that dampen protective immunity and limit the efficacy of immunotherapies<sup><CitationRef AdditionalCitationIDS="CR2 CR3" CitationID="CR1">1</CitationRef>–<CitationRef CitationID="CR4">4</CitationRef></sup>. The mechanisms that underlie T cell exhaustion remain poorly understood. Here we analyse the proteome of CD8<sup>+</sup> exhausted T (T<sub>ex</sub>) cells across multiple states of exhaustion in the context of both chronic viral infections and cancer. We show that there is a non-stochastic pathway-specific discordance between mRNA and protein dynamics between T effector (T<sub>eff</sub>) and T<sub>ex</sub> cells. We identify a distinct proteotoxic stress response (PSR) in T<sub>ex</sub> cells, which we term T<sub>ex</sub>-PSR. Contrary to canonical stress responses that induce a reduction in protein synthesis<sup><CitationRef CitationID="CR5">5</CitationRef>,<CitationRef CitationID="CR6">6</CitationRef></sup>, T<sub>ex</sub>-PSR involves an increase in global translation activity and an upregulation of specialized chaperone proteins. T<sub>ex</sub>-PSR is further characterized by the accumulation of protein aggregates and stress granules and an increase in autophagy-dominant protein catabolism. We establish that disruption of proteostasis alone can convert T<sub>eff</sub> cells to T<sub>ex</sub> cells, and we link T<sub>ex</sub>-PSR mechanistically to persistent AKT signalling. Finally, disruption of T<sub>ex</sub>-PSR-associated chaperones in CD8<sup>+</sup> T cells improves cancer immunotherapy in preclinical models. Moreover, a high T<sub>ex</sub>-PSR in T cells from patients with cancer confers poor responses to clinical immunotherapy. Collectively, our findings indicate that T<sub>ex</sub>-PSR is a hallmark and a mechanistic driver of T cell exhaustion, which raises the possibility of targeting proteostasis pathways&#xa0;as an approach for cancer immunotherapy.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Proteotoxic stress response drives T cell exhaustion and immune evasion

  • Yi Wang,
  • Anjun Ma,
  • No-Joon Song,
  • Ariana E. Shannon,
  • Yaa S. Amankwah,
  • Xingyu Chen,
  • Weidong Wu,
  • Ziyu Wang,
  • Abbey A. Saadey,
  • Amir Yousif,
  • Gautam Ghosh,
  • Jay K. Mandula,
  • Maria Velegraki,
  • Tong Xiao,
  • Haitao Wen,
  • Stanley Ching-Cheng Huang,
  • Ruoning Wang,
  • Christian M. Beusch,
  • Abdelhameed S. Dawood,
  • David E. Gordon,
  • Mohamed S. Abdel-Hakeem,
  • Hazem E. Ghoneim,
  • Gang Xin,
  • Brian C. Searle,
  • Zihai Li

摘要

Chronic infections and cancer cause T cell dysfunction known as exhaustion. This cell state is caused by persistent antigen exposure, suboptimal co-stimulation and a plethora of hostile factors that dampen protective immunity and limit the efficacy of immunotherapies14. The mechanisms that underlie T cell exhaustion remain poorly understood. Here we analyse the proteome of CD8+ exhausted T (Tex) cells across multiple states of exhaustion in the context of both chronic viral infections and cancer. We show that there is a non-stochastic pathway-specific discordance between mRNA and protein dynamics between T effector (Teff) and Tex cells. We identify a distinct proteotoxic stress response (PSR) in Tex cells, which we term Tex-PSR. Contrary to canonical stress responses that induce a reduction in protein synthesis5,6, Tex-PSR involves an increase in global translation activity and an upregulation of specialized chaperone proteins. Tex-PSR is further characterized by the accumulation of protein aggregates and stress granules and an increase in autophagy-dominant protein catabolism. We establish that disruption of proteostasis alone can convert Teff cells to Tex cells, and we link Tex-PSR mechanistically to persistent AKT signalling. Finally, disruption of Tex-PSR-associated chaperones in CD8+ T cells improves cancer immunotherapy in preclinical models. Moreover, a high Tex-PSR in T cells from patients with cancer confers poor responses to clinical immunotherapy. Collectively, our findings indicate that Tex-PSR is a hallmark and a mechanistic driver of T cell exhaustion, which raises the possibility of targeting proteostasis pathways as an approach for cancer immunotherapy.